Skip to content
healthcare.dev

mitoXANTRONE

NDC 71288-178, mitoXANTRONE, injection, solution, concentrate, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-178
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077356
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-178 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MITOXANTRONE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
71288-178-10712880178101 VIAL, MULTI-DOSE in 1 CARTON (71288-178-10) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1634528a-30c5-4309-acc8-4c0293ae14ae
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71288-178

Use it

Look up 71288-178 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-178 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-178. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.